Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1126

1.

The recency ratio is related to CSF Amyloid Beta 1-42 levels in MCI-AD.

Bruno D, Gleason CE, Koscik RL, Pomara N, Zetterberg H, Blennow K, Johnson SC.

Int J Geriatr Psychiatry. 2018 Nov 14. doi: 10.1002/gps.5029. [Epub ahead of print]

PMID:
30430632
2.

The Gothenburg H70 Birth cohort study 2014-16: design, methods and study population.

Rydberg Sterner T, Ahlner F, Blennow K, Dahlin-Ivanoff S, Falk H, Havstam Johansson L, Hoff M, Holm M, Hörder H, Jacobsson T, Johansson B, Johansson L, Kern J, Kern S, Machado A, Mellqvist Fässberg M, Nilsson J, Ribbe M, Rothenberg E, Rydén L, Sadeghi A, Sacuiu S, Samuelsson J, Sigström R, Skoog J, Thorvaldsson V, Waern M, Westman E, Wetterberg H, Zetterberg H, Zetterberg M, Zettergren A, Östling S, Skoog I.

Eur J Epidemiol. 2018 Nov 13. doi: 10.1007/s10654-018-0459-8. [Epub ahead of print]

PMID:
30421322
3.

Association of Cerebrospinal Fluid Neurofilament Light Protein With Risk of Mild Cognitive Impairment Among Individuals Without Cognitive Impairment.

Kern S, Syrjanen JA, Blennow K, Zetterberg H, Skoog I, Waern M, Hagen CE, van Harten AC, Knopman DS, Jack CR Jr, Petersen RC, Mielke MM.

JAMA Neurol. 2018 Nov 12. doi: 10.1001/jamaneurol.2018.3459. [Epub ahead of print]

PMID:
30419087
4.

CSF sTREM2 in delirium-relation to Alzheimer's disease CSF biomarkers Aβ42, t-tau and p-tau.

Henjum K, Quist-Paulsen E, Zetterberg H, Blennow K, Nilsson LNG, Watne LO.

J Neuroinflammation. 2018 Nov 3;15(1):304. doi: 10.1186/s12974-018-1331-1.

5.

Serum Neurofilament Light Chain for Prognosis of Outcome After Cardiac Arrest.

Moseby-Knappe M, Mattsson N, Nielsen N, Zetterberg H, Blennow K, Dankiewicz J, Dragancea I, Friberg H, Lilja G, Insel PS, Rylander C, Westhall E, Kjaergaard J, Wise MP, Hassager C, Kuiper MA, Stammet P, Wanscher MCJ, Wetterslev J, Erlinge D, Horn J, Pellis T, Cronberg T.

JAMA Neurol. 2018 Oct 29. doi: 10.1001/jamaneurol.2018.3223. [Epub ahead of print]

PMID:
30383090
6.

Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study.

Bäckström D, Granåsen G, Domellöf ME, Linder J, Jakobson Mo S, Riklund K, Zetterberg H, Blennow K, Forsgren L.

Neurology. 2018 Oct 31. pii: 10.1212/WNL.0000000000006576. doi: 10.1212/WNL.0000000000006576. [Epub ahead of print]

PMID:
30381367
7.

No change in plasma tau and serum neurofilament light concentrations in adolescent athletes following sport-related concussion.

Wallace C, Zetterberg H, Blennow K, van Donkelaar P.

PLoS One. 2018 Oct 29;13(10):e0206466. doi: 10.1371/journal.pone.0206466. eCollection 2018.

8.

Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms.

Palmqvist S, Insel PS, Zetterberg H, Blennow K, Brix B, Stomrud E; Alzheimer's Disease Neuroimaging Initiative; Swedish BioFINDER study, Mattsson N, Hansson O.

Alzheimers Dement. 2018 Oct 23. pii: S1552-5260(18)33524-6. doi: 10.1016/j.jalz.2018.08.014. [Epub ahead of print]

9.

Expression and secretion of synaptic proteins during stem cell differentiation to cortical neurons.

Nazir FH, Becker B, Brinkmalm A, Höglund K, Sandelius Å, Bergström P, Satir TM, Öhrfelt A, Blennow K, Agholme L, Zetterberg H.

Neurochem Int. 2018 Dec;121:38-49. doi: 10.1016/j.neuint.2018.10.014. Epub 2018 Oct 18.

10.

Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology.

Sandelius Å, Portelius E, Källén Å, Zetterberg H, Rot U, Olsson B, Toledo JB, Shaw LM, Lee VMY, Irwin DJ, Grossman M, Weintraub D, Chen-Plotkin A, Wolk DA, McCluskey L, Elman L, Kostanjevecki V, Vandijck M, McBride J, Trojanowski JQ, Blennow K.

Alzheimers Dement. 2018 Oct 12. pii: S1552-5260(18)33515-5. doi: 10.1016/j.jalz.2018.08.006. [Epub ahead of print]

11.

Vitamin D supplementation and neurofilament light chain in multiple sclerosis.

Holmøy T, Røsjø E, Zetterberg H, Blennow K, Lindstrøm JC, Steffensen LH, Kampman MT.

Acta Neurol Scand. 2018 Oct 13. doi: 10.1111/ane.13037. [Epub ahead of print]

PMID:
30317548
12.

Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease.

Shaw LM, Arias J, Blennow K, Galasko D, Molinuevo JL, Salloway S, Schindler S, Carrillo MC, Hendrix JA, Ross A, Illes J, Ramus C, Fifer S.

Alzheimers Dement. 2018 Nov;14(11):1505-1521. doi: 10.1016/j.jalz.2018.07.220. Epub 2018 Oct 10. Review.

PMID:
30316776
13.

Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic.

Hampel H, O'Bryant SE, Molinuevo JL, Zetterberg H, Masters CL, Lista S, Kiddle SJ, Batrla R, Blennow K.

Nat Rev Neurol. 2018 Nov;14(11):639-652. doi: 10.1038/s41582-018-0079-7. Review.

PMID:
30297701
14.

Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease.

Kruse N, Heslegrave A, Gupta V, Foiani M, Villar-Piqué A, Schmitz M, Lehmann S, Teunissen C, Blennow K, Zetterberg H, Mollenhauer B, Zerr I, Llorens F.

Alzheimers Dement (Amst). 2018 Jul 7;10:461-470. doi: 10.1016/j.dadm.2018.06.005. eCollection 2018.

15.

GM1 locates to mature amyloid structures implicating a prominent role for glycolipid-protein interactions in Alzheimer pathology.

Michno W, Wehrli PM, Zetterberg H, Blennow K, Hanrieder J.

Biochim Biophys Acta Proteins Proteom. 2018 Sep 28. pii: S1570-9639(18)30164-X. doi: 10.1016/j.bbapap.2018.09.010. [Epub ahead of print]

PMID:
30273679
16.

Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease.

Ostrowitzki S, Lasser RA, Dorflinger E, Scheltens P, Barkhof F, Nikolcheva T, Ashford E, Retout S, Hofmann C, Delmar P, Klein G, Andjelkovic M, Dubois B, Boada M, Blennow K, Santarelli L, Fontoura P; SCarlet RoAD Investigators.

Alzheimers Res Ther. 2018 Sep 27;10(1):99. doi: 10.1186/s13195-018-0409-4.

17.

Effects of methylprednisolone on blood-brain barrier and cerebral inflammation in cardiac surgery-a randomized trial.

Danielson M, Reinsfelt B, Westerlind A, Zetterberg H, Blennow K, Ricksten SE.

J Neuroinflammation. 2018 Sep 27;15(1):283. doi: 10.1186/s12974-018-1318-y.

18.

Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementia.

Oh ES, Blennow K, Bigelow GE, Inouye SK, Marcantonio ER, Neufeld KJ, Rosenberg PB, Troncoso JC, Wang NY, Zetterberg H, Sieber FE, Lyketsos CG.

PLoS One. 2018 Sep 25;13(9):e0204695. doi: 10.1371/journal.pone.0204695. eCollection 2018. Erratum in: PLoS One. 2018 Oct 26;13(10):e0206719.

19.

Cerebrospinal fluid protein markers in PD patients after DBS-STN surgery-A retrospective analysis of patients that underwent surgery between 1993 and 2001.

Constantinescu R, Blennow K, Rosengren L, Eriksson B, Gudmundsdottir T, Jansson Y, Johnels B, Renck A, Bergquist F.

Clin Neurol Neurosurg. 2018 Nov;174:174-179. doi: 10.1016/j.clineuro.2018.09.024. Epub 2018 Sep 17.

PMID:
30248592
20.

The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer's disease.

Kvartsberg H, Lashley T, Murray CE, Brinkmalm G, Cullen NC, Höglund K, Zetterberg H, Blennow K, Portelius E.

Acta Neuropathol. 2018 Sep 22. doi: 10.1007/s00401-018-1910-3. [Epub ahead of print]

PMID:
30244311
21.

Fluid-based proteomics targeted on pathophysiological processes and pathologies in neurodegenerative diseases.

Brinkmalm A, Portelius E, Brinkmalm G, Pannee J, Dahlén R, Gobom J, Blennow K, Zetterberg H.

J Neurochem. 2018 Sep 20. doi: 10.1111/jnc.14594. [Epub ahead of print] Review.

PMID:
30238462
22.

Heading in soccer increases serum neurofilament light protein and SCAT3 symptom metrics.

Wallace C, Smirl JD, Zetterberg H, Blennow K, Bryk K, Burma J, Dierijck J, Wright AD, van Donkelaar P.

BMJ Open Sport Exerc Med. 2018 Aug 27;4(1):e000433. doi: 10.1136/bmjsem-2018-000433. eCollection 2018.

23.

Therapeutic potential for peripheral clearance of misfolded brain proteins.

de Leon MJ, Blennow K.

Nat Rev Neurol. 2018 Nov;14(11):637-638. doi: 10.1038/s41582-018-0071-2. No abstract available.

PMID:
30214047
24.

Data driven diagnostic classification in Alzheimer's disease based on different reference regions for normalization of PiB-PET images and correlation with CSF concentrations of Aβ species.

Oliveira F, Leuzy A, Castelhano J, Chiotis K, Hasselbalch SG, Rinne J, Mendonça A, Otto M, Lleó A, Santana I, Johansson J, Anderl-Straub S, Arnim C, Beer A, Blesa R, Fortea J, Sanna-Kaisa H, Portelius E, Pannee J, Zetterberg H, Blennow K, Moreira AP, Abrunhosa A, Nordberg A, Castelo-Branco M.

Neuroimage Clin. 2018 Aug 19;20:603-610. doi: 10.1016/j.nicl.2018.08.023. eCollection 2018.

25.

Neurofilaments as biomarkers in neurological disorders.

Khalil M, Teunissen CE, Otto M, Piehl F, Sormani MP, Gattringer T, Barro C, Kappos L, Comabella M, Fazekas F, Petzold A, Blennow K, Zetterberg H, Kuhle J.

Nat Rev Neurol. 2018 Oct;14(10):577-589. doi: 10.1038/s41582-018-0058-z. Review.

PMID:
30171200
26.

Alzheimer-associated cerebrospinal fluid fragments of neurogranin are generated by Calpain-1 and prolyl endopeptidase.

Becker B, Nazir FH, Brinkmalm G, Camporesi E, Kvartsberg H, Portelius E, Boström M, Kalm M, Höglund K, Olsson M, Zetterberg H, Blennow K.

Mol Neurodegener. 2018 Aug 29;13(1):47. doi: 10.1186/s13024-018-0279-z.

27.

Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer's disease.

Lewczuk P, Gaignaux A, Kofanova O, Ermann N, Betsou F, Brandner S, Mroczko B, Blennow K, Strapagiel D, Paciotti S, Vogelgsang J, Roehrl MH, Mendoza S, Kornhuber J, Teunissen C.

Alzheimers Res Ther. 2018 Aug 28;10(1):87. doi: 10.1186/s13195-018-0418-3.

28.

Midlife Stress in Relation to Late-Life Cerebrospinal Fluid Biomarkers of Alzheimer's Disease: A 25-Year Follow-Up Study.

Johansson L, Kern S, Zetterberg H, Blennow K, Börjesson-Hansson A, Rosengren L, Guo X, Skoog I.

Dement Geriatr Cogn Disord. 2018;46(1-2):90-99. doi: 10.1159/000490885. Epub 2018 Aug 24.

PMID:
30145588
29.

Biology/Disease-Driven Initiative on Protein-Aggregation Diseases of the Human Proteome Project: Goals and Progress to Date.

Boersema PJ, Melnik A, Hazenberg BPC, Rezeli M, Marko-Varga G, Kamiie J, Portelius E, Blennow K, Zubarev RA, Polymenidou M, Picotti P.

J Proteome Res. 2018 Sep 28. doi: 10.1021/acs.jproteome.8b00401. [Epub ahead of print]

PMID:
30137990
30.

Antibody-based methods for the measurement of α-synuclein concentration in human cerebrospinal fluid - method comparison and round robin study.

Mollenhauer B, Bowman FD, Drake D, Duong J, Blennow K, El-Agnaf O, Shaw LM, Masucci J, Taylor P, Umek RM, Dunty JM, Smith CL, Stoops E, Vanderstichele H, Schmid AW, Moniatte M, Zhang J, Kruse N, Lashuel HA, Teunissen C, Schubert T, Dave KD, Hutten SJ, Zetterberg H.

J Neurochem. 2018 Aug 20. doi: 10.1111/jnc.14569. [Epub ahead of print]

PMID:
30125936
31.

Biomarkers for Antidepressant Efficacy of Electroconvulsive Therapy: An Exploratory Cerebrospinal Fluid Study.

Kranaster L, Hoyer C, Aksay SS, Bumb JM, Müller N, Zill P, Schwarz MJ, Moll N, Lutz B, Bindila L, Zerr I, Schmitz M, Blennow K, Zetterberg H, Haffner D, Leifheit-Nestler M, Ozbalci C, Janke C, Thiel M, Sartorius A.

Neuropsychobiology. 2018 Aug 17:1-10. doi: 10.1159/000491401. [Epub ahead of print]

PMID:
30121652
32.

Effects of APOE ε4 on neuroimaging, cerebrospinal fluid biomarkers, and cognition in prodromal Alzheimer's disease.

Mattsson N, Eriksson O, Lindberg O, Schöll M, Lampinen B, Nilsson M, Insel PS, Lautner R, Strandberg O, van Westen D, Zetterberg H, Blennow K, Palmqvist S, Stomrud E, Hansson O.

Neurobiol Aging. 2018 Nov;71:81-90. doi: 10.1016/j.neurobiolaging.2018.07.003. Epub 2018 Jul 11.

PMID:
30107289
33.

Neurofilament light chain in blood is negatively associated with neuropsychological performance in HIV-infected adults and declines with initiation of antiretroviral therapy.

Anderson AM, Easley KA, Kasher N, Franklin D, Heaton RK, Zetterberg H, Blennow K, Gisslen M, Letendre SL.

J Neurovirol. 2018 Aug 13. doi: 10.1007/s13365-018-0664-y. [Epub ahead of print]

PMID:
30105502
34.

Cerebrospinal fluid GAP-43 in early multiple sclerosis.

Rot U, Sandelius Å, Emeršič A, Zetterberg H, Blennow K.

Mult Scler J Exp Transl Clin. 2018 Aug 7;4(3):2055217318792931. doi: 10.1177/2055217318792931. eCollection 2018 Jul-Sep.

35.

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer's disease.

Lewczuk P, Ermann N, Andreasson U, Schultheis C, Podhorna J, Spitzer P, Maler JM, Kornhuber J, Blennow K, Zetterberg H.

Alzheimers Res Ther. 2018 Jul 28;10(1):71. doi: 10.1186/s13195-018-0404-9.

36.

Association of cerebrospinal fluid α-synuclein with total and phospho-tau181 protein concentrations and brain amyloid load in cognitively normal subjective memory complainers stratified by Alzheimer's disease biomarkers.

Vergallo A, Bun RS, Toschi N, Baldacci F, Zetterberg H, Blennow K, Cavedo E, Lamari F, Habert MO, Dubois B, Floris R, Garaci F, Lista S, Hampel H; INSIGHT-preAD study group; Alzheimer Precision Medicine Initiative (APMI).

Alzheimers Dement. 2018 Jul 26. pii: S1552-5260(18)33241-2. doi: 10.1016/j.jalz.2018.06.3053. [Epub ahead of print]

PMID:
30055132
37.

Evidence for sex difference in the CSF/plasma albumin ratio in ~20 000 patients and 335 healthy volunteers.

Parrado-Fernández C, Blennow K, Hansson M, Leoni V, Cedazo-Minguez A, Björkhem I.

J Cell Mol Med. 2018 Oct;22(10):5151-5154. doi: 10.1111/jcmm.13767. Epub 2018 Jul 27.

38.

CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease.

Janelidze S, Mattsson N, Stomrud E, Lindberg O, Palmqvist S, Zetterberg H, Blennow K, Hansson O.

Neurology. 2018 Aug 28;91(9):e867-e877. doi: 10.1212/WNL.0000000000006082. Epub 2018 Jul 27.

39.

Biomarkers for Alzheimer's disease: current status and prospects for the future.

Blennow K, Zetterberg H.

J Intern Med. 2018 Jul 26. doi: 10.1111/joim.12816. [Epub ahead of print] Review.

PMID:
30051512
40.

Cerebrospinal fluid tau, Aβ, and sTREM2 in Former National Football League Players: Modeling the relationship between repetitive head impacts, microglial activation, and neurodegeneration.

Alosco ML, Tripodis Y, Fritts NG, Heslegrave A, Baugh CM, Conneely S, Mariani M, Martin BM, Frank S, Mez J, Stein TD, Cantu RC, McKee AC, Shaw LM, Trojanowski JQ, Blennow K, Zetterberg H, Stern RA.

Alzheimers Dement. 2018 Sep;14(9):1159-1170. doi: 10.1016/j.jalz.2018.05.004. Epub 2018 Jul 23.

PMID:
30049650
41.

Levels of ADAM10 are reduced in Alzheimer's disease CSF.

Sogorb-Esteve A, García-Ayllón MS, Gobom J, Alom J, Zetterberg H, Blennow K, Sáez-Valero J.

J Neuroinflammation. 2018 Jul 25;15(1):213. doi: 10.1186/s12974-018-1255-9.

42.

Molecular imaging mass spectrometry for probing protein dynamics in neurodegenerative disease pathology.

Michno W, Wehrli PM, Blennow K, Zetterberg H, Hanrieder J.

J Neurochem. 2018 Jul 24. doi: 10.1111/jnc.14559. [Epub ahead of print] Review.

PMID:
30040875
43.

Neurofilament relates to white matter microstructure in older adults.

Moore EE, Hohman TJ, Badami FS, Pechman KR, Osborn KE, Acosta LMY, Bell SP, Babicz MA, Gifford KA, Anderson AW, Goldstein LE, Blennow K, Zetterberg H, Jefferson AL.

Neurobiol Aging. 2018 Oct;70:233-241. doi: 10.1016/j.neurobiolaging.2018.06.023. Epub 2018 Jun 28.

PMID:
30036759
44.

The presubiculum is preserved from neurodegenerative changes in Alzheimer's disease.

Murray CE, Gami-Patel P, Gkanatsiou E, Brinkmalm G, Portelius E, Wirths O, Heywood W, Blennow K, Ghiso J, Holton JL, Mills K, Zetterberg H, Revesz T, Lashley T.

Acta Neuropathol Commun. 2018 Jul 20;6(1):62. doi: 10.1186/s40478-018-0563-8.

45.

Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis.

Håkansson I, Tisell A, Cassel P, Blennow K, Zetterberg H, Lundberg P, Dahle C, Vrethem M, Ernerudh J.

J Neuroinflammation. 2018 Jul 18;15(1):209. doi: 10.1186/s12974-018-1249-7.

46.

Socioeconomic status, gender and dementia: The influence of work environment exposures and their interactions with APOE ɛ4.

Hasselgren C, Dellve L, Ekbrand H, Zettergren A, Zetterberg H, Blennow K, Skoog I, Halleröd B.

SSM Popul Health. 2018 Jun 22;5:171-179. doi: 10.1016/j.ssmph.2018.06.009. eCollection 2018 Aug.

47.

No association of salivary total tau concentration with Alzheimer's disease.

Ashton NJ, Ide M, Schöll M, Blennow K, Lovestone S, Hye A, Zetterberg H.

Neurobiol Aging. 2018 Oct;70:125-127. doi: 10.1016/j.neurobiolaging.2018.06.014. Epub 2018 Jun 20.

PMID:
30007161
48.

Cerebrospinal fluid neurofilament light is associated with survival in mitochondrial disease patients.

Sofou K, Shahim P, Tulinius M, Blennow K, Zetterberg H, Mattsson N, Darin N.

Mitochondrion. 2018 Jul 9. pii: S1567-7249(18)30022-9. doi: 10.1016/j.mito.2018.07.002. [Epub ahead of print]

PMID:
30004022
49.

The anti-asthmatic drug, montelukast, modifies the neurogenic potential in the young healthy and irradiated brain.

Eriksson Y, Boström M, Sandelius Å, Blennow K, Zetterberg H, Kuhn G, Kalm M.

Cell Death Dis. 2018 Jul 10;9(7):775. doi: 10.1038/s41419-018-0783-7.

50.

Sex-specific genetic predictors of Alzheimer's disease biomarkers.

Deming Y, Dumitrescu L, Barnes LL, Thambisetty M, Kunkle B, Gifford KA, Bush WS, Chibnik LB, Mukherjee S, De Jager PL, Kukull W, Huentelman M, Crane PK, Resnick SM, Keene CD, Montine TJ, Schellenberg GD, Haines JL, Zetterberg H, Blennow K, Larson EB, Johnson SC, Albert M, Moghekar A, Del Aguila JL, Fernandez MV, Budde J, Hassenstab J, Fagan AM, Riemenschneider M, Petersen RC, Minthon L, Chao MJ, Van Deerlin VM, Lee VM, Shaw LM, Trojanowski JQ, Peskind ER, Li G, Davis LK, Sealock JM, Cox NJ; Alzheimer’s Disease Neuroimaging Initiative (ADNI); Alzheimer Disease Genetics Consortium (ADGC), Goate AM, Bennett DA, Schneider JA, Jefferson AL, Cruchaga C, Hohman TJ.

Acta Neuropathol. 2018 Jul 2. doi: 10.1007/s00401-018-1881-4. [Epub ahead of print]

PMID:
29967939

Supplemental Content

Loading ...
Support Center